Biotech Industry Looks to Benefit From FDA-s New “Breakthrough” Designation

Five Star Equities Provides Stock Research on Celldex Therapeutics and DARA Biosciences

Continue Reading

Programs by the FDA Designed to Speed Up Approval Process for Critical Drugs a Key Factor in Biotech-s Industry Success

Five Star Equities Provides Stock Research on Exelixis and Lexicon Pharmaceuticals

Continue Reading

Natural Gas Prices Surging in 2013 Due to Warm Weather and Falling Supplies

Five Star Equities Provides Stock Research on Quicksilver Resources and Cheniere Energy

Continue Reading

Natural Gas Producers Surge as Futures Reach a 16-Month High

Five Star Equities Provides Stock Research on Chesapeake Energy and Southwestern Energy

Continue Reading

FDA-s New “Breakthrough” Designation Allows New Drugs to Gain Approval after Just 1 Round of Testing

Five Star Equities Provides Stock Research on Oncolytics Biotech and XOMA

Continue Reading

New Programs Designed to Speed up Approval Process a Key Factor in Biotech Industry-s Growth in 2012

Five Star Equities Provides Stock Research on ImmunoCellular and Nektar

Continue Reading

Programs by the FDA Designed to Speed Up Approval Process for Critical Drugs a Key Factor in Biotech-s Industry Success

Five Star Equities Provides Stock Research on ArQule and Vanda Pharmaceuticals

Continue Reading

Long-Term Demand for Uranium to Be Driven by Emerging Nation – Miners Could Receive Boost From End of Russia-s Disarmament Treaty

Five Star Equities Provides Stock Research on Uranium Energy and Uranium Resources

Continue Reading

Biotech Industry Looks to Benefit From FDA-s New “Breakthrough” Designation

Five Star Equities Provides Stock Research on Athersys and Zogenix

Continue Reading

Retail Industry Showing Strength in 2013 as Commerce Department Reports 1.1% Increase in February Sales

Five Star Equities Provides Stock Research on Foot Locker and Zumiez

Continue Reading